Medicinal leech therapy-an overall perspective

被引:76
作者
Sig, Ali K. [1 ]
Guney, Mustafa [2 ]
Guclu, Aylin Uskudar [2 ]
Ozmen, Erkan [3 ]
机构
[1] Publ Hlth Inst Turkey, Erzurum Publ Hlth Lab, Erzurum, Turkey
[2] Univ Hlth Sci, Gulhane Med Fac, Dept Med Microbiol, Ankara, Turkey
[3] Ataturk Univ, Med Fac, Dept Med Microbiol, Erzurum, Turkey
关键词
Hirudo medicinalis; hirudotherapy; leech; VERONII BIOVAR SOBRIA; HIRUDO-MEDICINALIS; TRYPTASE INHIBITOR; PLATELET-AGGREGATION; PHAGE DISPLAY; COAGULATION; LYSOZYME; DESTABILASE; SALIVA; PURIFICATION;
D O I
10.1016/j.imr.2017.08.001
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Complementary medicine methods have a long history, but modern medicine has just recently focused on their possible modes of action. Medicinal leech therapy (MLT) or himdotherapy, an old technique, has been studied by many researchers for possible effects on various diseases such as inflammatory diseases, osteoarthritis, and after different surgeries. Hirudo medicinalis has widest therapeutic usage among the leeches, but worldwide, many different species were tested and studied. Leeches secrete more than 20 identified bioactive substances such as antistasin, eglins, guamerin, hirudin, saratin, bdellins, complement, and carboxypeptidase inhibitors. They have analgesic, anti-inflammatory, platelet inhibitory, anticoagulant, and thrombin regulatory functions, as well as extracellular matrix degradative and antimicrobial effects, but with further studies, the spectrum of effects may widen. The technique is cheap, effective, easy to apply, and its modes of action have been elucidated for certain diseases. In conclusion, for treatment of some diseases, MLT is not an alternative, but is a complementary and/or integrative choice. MLT is a part of multidisciplinary treatments, and secretes various bioactive substances. These substances vary among species and different species should be evaluated for both treatment capability and their particular secreted molecules. There is huge potential for novel substances and these could be future therapeutics. (C) 2017 Korea Institute of Oriental Medicine. Published by Elsevier. This is an open access article under the CC BY-NC-ND license
引用
收藏
页码:337 / 343
页数:7
相关论文
共 71 条
  • [1] Abdualkader AM, 2013, INDIAN J PHARM SCI, V75, P127
  • [2] Abdullah S., 2012, Arch Clin Exp Surg, V1, P172, DOI [10.5455/aces.20120402072447, DOI 10.5455/ACES.20120402072447]
  • [3] Vascular-platelet and plasma hemostasis regulators from bloodsucking animals
    Basanova, AV
    Baskova, IP
    Zavalova, LL
    [J]. BIOCHEMISTRY-MOSCOW, 2002, 67 (01) : 143 - 150
  • [4] Protein profiling of the medicinal leech salivary gland secretion by proteoinic analytical methods
    Baskova, IP
    Zavalova, LL
    Basanova, AV
    Moshkovskii, SA
    Zgoda, VG
    [J]. BIOCHEMISTRY-MOSCOW, 2004, 69 (07) : 770 - 775
  • [5] Separation of monomerizing and lysozyme activities of destabilase from medicinal leech salivary gland secretion
    Baskova, IP
    Zavalova, LL
    Basanova, AV
    Sass, AV
    [J]. BIOCHEMISTRY-MOSCOW, 2001, 66 (12) : 1368 - 1373
  • [6] Proteinase inhibitors from the medicinal leech Hirudo medicinalis
    Baskova, IP
    Zavalova, LL
    [J]. BIOCHEMISTRY-MOSCOW, 2001, 66 (07) : 703 - 714
  • [7] AMINO-ACID-SEQUENCE OF GHILANTEN - ANTICOAGULANT-ANTIMETASTATIC PRINCIPLE OF THE SOUTH-AMERICAN LEECH, HAEMENTERIA-GHILIANII
    BLANKENSHIP, DT
    BRANKAMP, RG
    MANLEY, GD
    CARDIN, AD
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1990, 166 (03) : 1384 - 1389
  • [8] Evaluation of phage display system and leech-derived tryptase inhibitor as a tool for understanding the serine proteinase specificities
    Campos, ITN
    Silva, MM
    Azzolini, SS
    Souza, AF
    Sampaio, CAM
    Fritz, H
    Tanaka, AS
    [J]. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2004, 425 (01) : 87 - 94
  • [9] Mast cell proteases as pharmacological targets
    Caughey, George H.
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2016, 778 : 44 - 55
  • [10] Cherniack EP, 2011, ALTERN MED REV, V16, P50